Document:

Exhibit
10.2

 

AMENDED
AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

THIS
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), effective as of the [●] day of
[●], 2022 (the “Effective Date”), is made and entered into by and among (i) 8i Acquisition 2 Corp., a
British Virgin Islands company (the “Company”), (ii) each of the undersigned parties that are Pre-BC Investors
(as defined below), (iii) Watermark Developments Limited, a British Virgin Islands Company (the “Euda Investor”)
the sole shareholder of Euda Health Limited (“Euda”), a British Virgin Islands company, and (iv) Menora Capital
Pte Ltd. (the “Advisor”)(each of the foregoing parties (other than the Company) and any Person (as defined below) who hereafter
becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, an “Investor” and collectively,
the “Investors”);

 

WHEREAS,
the Company and the Sponsor are parties to a certain Registration Rights Agreement, dated November 22, 2021 (the “Original
Registration Rights Agreement”), pursuant to which the Company granted the Sponsor certain registration rights with respect
to certain securities of the Company, as set forth therein;

 

WHEREAS,
the Company, Euda, the Euda Investor and Kwong Yeow Liew have entered into that certain Share Purchase Agreement (as it may be amended
from time to time, the “SPA”), dated as of April __________, 2022, pursuant to which, on the Closing Date (as
defined below), the Company acquired all of the issued and outstanding ordinary shares of Euda from the Euda Investor (the “Transaction”);

 

WHEREAS,
Euda and the Advisor have entered into that certain agreement dated August 2, 2021 (the “Advisor Agreement”)
pursuant to which the Company has agreed to issue to the Advisor 200,000 Ordinary Shares of the Company upon completion of the Transaction;

 

WHEREAS,
the Investors and the Company desire to enter into this Agreement in connection with the Closing of the Transaction to amend and restate
the Original Registration Rights Agreement to provide the Investors with certain rights relating to the registration of the securities
held by them as of the Closing on the terms and conditions set forth in this Agreement;

 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

1.
DEFINITIONS. The following capitalized terms used herein have the following meanings:

 

“Advisor”
is defined in the preamble to this Agreement.

 

“Advisor
Agreement” is defined in the third Whereas clause.

 

“Agreement”
means this Agreement, as amended, restated, supplemented, or otherwise modified from time to time.

 

    	 

     

    

 

“Business
Combination” means the acquisition of direct or indirect ownership through a merger, share exchange, asset acquisition,
share purchase, recapitalization, reorganization or other similar type of transaction, of one or more businesses or entities.

 

“Commission”
means the Securities and Exchange Commission, or any other Federal agency then administering the Securities Act or the Exchange Act.

 

“Company”
is defined in the preamble to this Agreement.

 

“Closing
Date” means the date of the closing of the Transaction.

 

“Effectiveness
Date” means, with respect to the Registration Statement, the 90th calendar day following the Filing Date (or in the event
the Registration Statement receives a “full review” by the Commission, the 120th day following the Filing Date); provided,
however, that in the event the Company is notified by the Commission that one or more of the above Registration Statements will not be
reviewed or is no longer subject to further review and comments, the fifth Business Day following the date on which the Company is so
notified if such date precedes the dates otherwise required above; provided, further, that, if the Effectiveness Date falls on a Saturday,
Sunday or any other day which shall be a legal holiday or a day on which the Commission is authorized or required by law or other government
actions to close, the Effectiveness Date shall be the following Business Day.

 

“Effectiveness
Period” is defined in Section 2.1.1.

 

“Escrow
Agreement” means the Stock Escrow Agreement, dated November 22, 2021, by and among the Company, the shareholders listed
on Exhibit A attached thereto and American Stock Transfer & Trust Company.

 

“Euda”
is defined in the preamble to this Agreement.

 

“Euda
Investor” is defined in the preamble to this Agreement.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated
thereunder, all as the same shall be in effect at the time.

 

“Filing
Date” means no later than seven (7) calendar days after the Closing Date.

 

“Form
S-3” is defined in Section 2.3.

 

“Holder(s)”
means holder(s) of the Registrable Securities.

 

“Indemnified
Party” is defined in Section 4.3.

 

“Indemnifying
Party” is defined in Section 4.3.

 

“Initial
Shares” means 2,156,250 Ordinary Shares held by the Pre-BC Investors.

 

“Investor”
is defined in the preamble to this Agreement.

 

    	2

     

    

 

“Investor
Indemnified Party” is defined in Section 4.1.

 

“Lock-Up
Agreement” means the lock-up agreement pursuant to which the Ordinary Shares held by the Euda Investor shall be subject
to lock-up for a period of one year from the Closing Date.

 

“Maximum
Number of Shares” is defined in Section 2.1.4.

 

“Notices”
is defined in Section 6.3.

 

“Pre-BC
Investors” means the Sponsor, the officers and directors of the Company prior to the initial public offering of the Company’s
Ordinary Shares consummated on November 24, 2021.

 

“Pro
Rata” is defined in Section 2.1.4.

 

“Ordinary
Shares” means the ordinary shares of the Company, with no par value.

 

“Original
Registration Rights Agreement” is defined in the first Whereas clause.

 

“Private
Units” means the 292,250 Units owned by the Sponsor

 

“Register,”
“Registered” and “Registration” mean a registration effected by preparing and filing
a registration statement or similar document in compliance with the requirements of the Securities Act, and the applicable rules and
regulations promulgated thereunder, and such registration statement becoming effective.

 

“Registrable
Securities” means (i) the Initial Shares, (ii) the Private Units (and underlying securities), (iii) any securities issuable
upon conversion of loans from the Sponsor or affiliates of the Sponsor to the Company for the Company’s payment of its working
capital, if any (the “Working Capital Loan Securities”), (iv) the Ordinary Shares issued to the Euda Investor
in connection with the Transaction (the “Transaction Shares”) and (v) the 200,000 Ordinary Shares issued to
the Advisor pursuant to the Advisor Agreement. Registrable Securities include any warrants, rights, shares of capital stock or other
securities of the Company issued as a dividend or other distribution with respect to or in exchange for or in replacement of such Initial
Shares, Private Units (and underlying Ordinary Shares), Working Capital Loan Securities and the Transaction Shares. As to any particular
Registrable Securities, such securities shall cease to be Registrable Securities when: (a) a Registration Statement with respect to the
sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed
of or exchanged in accordance with such Registration Statement; (b) such securities shall have been otherwise transferred, new certificates
for them not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent public distribution
of them shall not require registration under the Securities Act; (c) such securities shall have ceased to be outstanding, or (d) the
Registrable Securities are freely saleable under Rule 144 without volume limitations.

 

    	3

     

    

 

“Registration
Statement” means a registration statement filed by the Company with the Commission in compliance with the Securities Act
and the rules and regulations promulgated thereunder for a public offering and sale of equity securities, or securities or other obligations
exercisable or exchangeable for, or convertible into, equity securities (other than a registration statement on Form S-4 or Form S-8,
or their successors, or any registration statement covering only securities proposed to be issued in exchange for securities or assets
of another entity).

 

“Release
Date” means the date on which the Initial Shares are disbursed from escrow pursuant to Section 3 of that certain Stock
Escrow Agreement dated as of November 22, 2021 by and among the Investors and American Stock Transfer & Trust Company, LLC.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations of the Commission promulgated thereunder,
all as the same shall be in effect at the time.

 

“SPA”
is defined in the second Whereas clause.

 

“Sponsor”
means 8i Holdings 2 Pte Ltd.

 

“Transaction”
is defined in the second Whereas clause.

 

“Transfer
Agent” means American Stock Transfer & Trust Company.

 

“Underwriter”
means a securities dealer who purchases any Registrable Securities as principal in an underwritten offering and not as part of such dealer’s
market-making activities.

 

“Units”
means the units of the Company, each comprised of one Ordinary Share, one redeemable Warrant to purchase one-half of one Ordinary Share,
and one right to receive one-tenth (1/10) of an Ordinary Share.

 

“Warrant(s)”
means the warrants of the Company.

 

2.
REGISTRATION RIGHTS.

 

2.1
Shelf Registration.

 

2.1.1
On or prior to the Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of
all or such maximum portion of the Registrable Securities as permitted by SEC guidance (provided that, the Company shall use diligent
efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC guidance,
including without limitation, the Manual of Publicly Available Telephone Interpretations D.29) that are not then registered on an effective
Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder
shall be on Form S-3 (except if the Company is then ineligible to register for resale the Registrable Securities on Form S-3, such registration
shall be on Form S-1 in accordance herewith) and shall contain the “Plan of Distribution” attached hereto as
Annex A. Subject to the terms of this Agreement, the Company shall use its commercially reasonable efforts to cause a Registration
Statement to be declared effective under the Securities Act as promptly as practicable after the filing thereof, but in any event prior
to the applicable Effectiveness Date, and shall use its commercially reasonable efforts to keep such Registration Statement continuously
effective under the Securities Act until all Registrable Securities covered by such Registration Statement have been sold, or may be
sold without volume or manner-of-sale restrictions pursuant to Rule 144, without the requirement for the Company to be in compliance
with the current public information requirement under Rule 144, as determined by the counsel to the Company pursuant to a written opinion
letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the “Effectiveness Period”).
The Company shall submit to the Commission a request for acceleration of the effectiveness of a Registration Statement as of 5:00 p.m.
New York City time on a Business Day. The Company shall promptly notify the Holders by e-mail of the effectiveness of a Registration
Statement on the same Business Day that the Company telephonically confirms effectiveness with the Commission. The Company shall, no
later than the second Business Day after the effective date of such Registration Statement, file a final Prospectus with the Commission
as required by Rule 424.

 

    	4

     

    

 

2.1.2
Notwithstanding any other provision of this Agreement, if any SEC guidance sets forth a limitation on the number of Registrable Securities
permitted to be registered on a particular Registration Statement (and notwithstanding that the Company used diligent efforts to advocate
with the Commission for the registration of all or a greater portion of Registrable Securities), the number of Registrable Securities
to be registered shall include the number of Registrable Securities reduced on a pro rata basis (in accordance with the number of shares
that each such person owns (such proportion is referred to herein as “Pro Rata”)). Promptly after such SEC
guidance is no longer applicable with respect to some or all of the remaining unregistered Registrable Securities, the Company shall
file an additional Registration Statement in accordance with this Section 2 with respect to such shares.

 

2.1.3
Each Holder agrees to furnish to the Company a completed Selling Shareholder Questionnaire within two (2) Business Days following the
date of this Agreement, a form of which will be provided by the Company together with this Agreement. Each Holder further acknowledges
and agrees that it shall not be entitled to be named as a selling shareholder in the Registration Statement or use the Prospectus for
offers and resales of Registrable Securities at any time, unless such Holder has returned to the Company a completed and signed Selling
Shareholder Questionnaire. If a Holder of Registrable Securities returns a Selling Shareholder Questionnaire after the deadline specified
in the previous sentence, the Company shall use its commercially reasonable efforts to take such actions as are required to name such
Holder as a selling shareholder in the Registration Statement or any pre-effective or post-effective amendment thereto and to include
(to the extent not theretofore included) in the Registration Statement the Registrable Securities identified in such late Selling Shareholder
Questionnaire; provided that the Company shall not be required to file an additional Registration Statement solely for such shares. Each
Holder acknowledges and agrees that the information in the Selling Shareholder Questionnaire will be used by the Company in the preparation
of the Registration Statement and hereby consents to the inclusion of such information in the Registration Statement.

 

2.1.4
Notwithstanding the foregoing, no sales of Registrable Shares under an effective registration statement shall be made until such time
that the restrictions on sales of Registrable Shares, as set forth in each of the Escrow Agreement for the Pre-BC Investors and the Lock-Up
Agreement for the Euda Investor, expire.

 

    	5

     

    

 

3.
REGISTRATION PROCEDURES.

 

3.1
Filings; Information. Whenever the Company is required to effect the registration of any Registrable Securities pursuant to Section
2, the Company shall use its best efforts to effect the registration and sale of such Registrable Securities in accordance with the intended
method(s) of distribution thereof as expeditiously as practicable, and in connection with any such request:

 

3.1.1
Copies. The Company shall, prior to filing a Registration Statement or prospectus, or any amendment or supplement thereto, furnish
without charge to the holders of Registrable Securities included in such registration, and such holders’ legal counsel, copies
of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including
all exhibits thereto and documents incorporated by reference therein), the prospectus included in such Registration Statement (including
each preliminary prospectus), and such other documents as the holders of Registrable Securities included in such registration or legal
counsel for any such holders may request in order to facilitate the disposition of the Registrable Securities owned by such holders.

 

3.1.2
Amendments and Supplements. The Company shall prepare and file with the Commission such amendments, including post-effective amendments,
and supplements to such Registration Statement and the prospectus used in connection therewith as may be necessary to keep such Registration
Statement effective and in compliance with the provisions of the Securities Act until all Registrable Securities and other securities
covered by such Registration Statement have been disposed of in accordance with the intended method(s) of distribution set forth in such
Registration Statement or such securities have been withdrawn.

 

3.1.3
Notification. After the filing of a Registration Statement, the Company shall promptly, and in no event more than two (2) business
days after such filing, notify the holders of Registrable Securities included in such Registration Statement of such filing, and shall
further notify such holders promptly and confirm such advice in writing in all events within two (2) business days of the occurrence
of any of the following: (i) receipt of a comment letter from the Commission; (ii) notification by the Commission that the Registration
Statement will not be reviewed or is no longer subject to further review and comments; (iii) when such Registration Statement becomes
effective; (iv) when any post-effective amendment to such Registration Statement becomes effective; (v) the issuance or threatened issuance
by the Commission of any stop order (and the Company shall take all actions required to prevent the entry of such stop order or to remove
it if entered); and (vi) any request by the Commission for any amendment or supplement to such Registration Statement or any prospectus
relating thereto or for additional information or of the occurrence of an event requiring the preparation of a supplement or amendment
to such prospectus so that, as thereafter delivered to the purchasers of the securities covered by such Registration Statement, such
prospectus will not contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein not misleading, and promptly make available to the holders of Registrable Securities included
in such Registration Statement any such supplement or amendment; except that before filing with the Commission a Registration Statement
or prospectus or any amendment or supplement thereto, including documents incorporated by reference, the Company shall furnish to the
holders of Registrable Securities included in such Registration Statement and to the legal counsel for any such holders, copies of all
such documents proposed to be filed sufficiently in advance of filing to provide such holders and legal counsel with a reasonable opportunity
to review such documents and comment thereon, and the Company shall not file any Registration Statement or prospectus or amendment or
supplement thereto, including documents incorporated by reference, to which such holders or their legal counsel shall object.

 

    	6

     

    

 

3.1.4
State Securities Laws Compliance. The Company shall use its best efforts to (i) register or qualify the Registrable Securities
covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States
as the holders of Registrable Securities included in such Registration Statement (in light of their intended Plan of Distribution) may
request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered
with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of the Company and
do any and all other acts and things that may be necessary or advisable to enable the holders of Registrable Securities included in such
Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that the
Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify
but for this paragraph or subject itself to taxation in any such jurisdiction.

 

3.1.5
Cooperation. The principal executive officer of the Company, the principal financial officer of the Company, the principal accounting
officer of the Company and all other officers and members of the management of the Company shall cooperate fully in any offering of Registrable
Securities hereunder, which cooperation shall include, without limitation, the preparation of the Registration Statement with respect
to such offering and all other offering materials and related documents, and participation in meetings with Underwriters, attorneys,
accountants and potential investors.

 

3.1.6
Agreements for Disposition. The Company shall enter into customary agreements and take such other actions as are reasonably required
in order to expedite or facilitate the registration of such Registrable Securities.

 

3.1.7
Records. The Company shall make available for inspection by the holders of Registrable Securities included in such Registration
Statement, any Underwriter participating in any disposition pursuant to such registration statement and any attorney, accountant or other
professional retained by any holder of Registrable Securities included in such Registration Statement or any Underwriter, all financial
and other records, pertinent corporate documents and properties of the Company, as shall be necessary to enable them to exercise their
due diligence responsibility, and cause the Company’s officers, directors and employees to supply all information requested by
any of them in connection with such Registration Statement.

 

3.1.8
Earnings Statement. The Company shall comply with all applicable rules and regulations of the Commission and the Securities Act,
and make available to its shareholders, as soon as practicable, an earnings statement covering a period of twelve (12) months, which
earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder.

 

    	7

     

    

 

3.1.9
Listing. The Company shall use its best efforts to cause all Registrable Securities included in any registration to be listed
on such exchanges or otherwise designated for trading in the same manner as similar securities issued by the Company are then listed
or designated or, if no such similar securities are then listed or designated, in a manner satisfactory to the holders of a majority
of the Registrable Securities included in such registration.

 

3.2
Obligation to Suspend Distribution. Upon receipt of any notice from the Company of the happening of any event of the kind described
in Section 3.1.4(iv), or, in the case of a resale registration on Form S-3 pursuant to Section 2.3 hereof, upon any suspension by the
Company, pursuant to a written insider trading compliance program adopted by the Company’s Board of Directors, of the ability of
all “insiders” covered by such program to transact in the Company’s securities because of the existence of material
non-public information, each holder of Registrable Securities included in any registration shall immediately discontinue disposition
of such Registrable Securities pursuant to the Registration Statement covering such Registrable Securities until such holder receives
the supplemented or amended prospectus contemplated by Section 3.1.4(iv) or the restriction on the ability of “insiders”
to transact in the Company’s securities is removed, as applicable, and, if so directed by the Company, each such holder will deliver
to the Company all copies, other than permanent file copies then in such holder’s possession, of the most recent prospectus covering
such Registrable Securities at the time of receipt of such notice.

 

3.3
Registration Expenses. The Company shall bear all costs and expenses incurred in connection with any Registration Statement, and
all expenses incurred in performing or complying with its other obligations under this Agreement, whether or not the Registration Statement
becomes effective, including, without limitation: (i) all registration and filing fees; (ii) fees and expenses of compliance with securities
or “blue sky” laws (including fees and disbursements of counsel in connection with blue sky qualifications of the Registrable
Securities); (iii) printing expenses; (iv) the Company’s internal expenses (including, without limitation, all salaries and expenses
of its officers and employees); (v) fees and disbursements of counsel for the Company and fees and expenses for independent certified
public accountants retained by the Company; (vi) the reasonable fees and expenses of any special experts retained by the Company in connection
with such registration, and (vii) the reasonable fees and expenses of one legal counsel selected by the holders of a majority-in-interest
of the Registrable Securities included in such registration, not to exceed $50,000 in the aggregate.

 

3.4
Information. The holders of Registrable Securities shall provide such information as may reasonably be requested by the Company,
or the managing Underwriter, if any, in connection with the preparation of any Registration Statement, including amendments and supplements
thereto, in order to effect the registration of any Registrable Securities under the Securities Act pursuant to Section 2 and in connection
with the Company’s obligation to comply with Federal and applicable state securities laws.

 

    	8

     

    

 

4.
INDEMNIFICATION AND CONTRIBUTION.

 

4.1
Indemnification by the Company. The Company agrees to indemnify and hold harmless each Investor and each other holder of Registrable
Securities, and each of their respective officers, employees, affiliates, directors, partners, members, attorneys and agents, and each
person, if any, who controls an Investor and each other holder of Registrable Securities (within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act) (each, an “Investor Indemnified Party”), from and against any expenses,
losses, judgments, claims, damages or liabilities, whether joint or several, arising out of or based upon any untrue statement (or allegedly
untrue statement) of a material fact contained in any Registration Statement under which the sale of such Registrable Securities was
registered under the Securities Act, any preliminary prospectus, final prospectus or summary prospectus contained in the Registration
Statement, or any amendment or supplement to such Registration Statement, or arising out of or based upon any omission (or alleged omission)
to state a material fact required to be stated therein or necessary to make the statements therein not misleading, or any violation by
the Company of the Securities Act or any rule or regulation promulgated thereunder applicable to the Company and relating to action or
inaction required of the Company in connection with any such registration; and the Company shall promptly reimburse the Investor Indemnified
Party for any legal and any other expenses reasonably incurred by such Investor Indemnified Party in connection with investigating and
defending any such expense, loss, judgment, claim, damage, liability or action; provided, however, that the Company will not be liable
in any such case to the extent that any such expense, loss, claim, damage or liability arises out of or is based upon any untrue statement
or allegedly untrue statement or omission or alleged omission made in such Registration Statement, preliminary prospectus, final prospectus,
or summary prospectus, or any such amendment or supplement, in reliance upon and in conformity with information furnished to the Company,
in writing, by such selling holder expressly for use therein. The Company also shall indemnify any Underwriter of the Registrable Securities,
their officers, affiliates, directors, partners, members and agents and each person who controls such Underwriter on substantially the
same basis as that of the indemnification provided above in this Section 4.1.

 

4.2
Indemnification by Holders of Registrable Securities. Each selling holder of Registrable Securities will, in the event that any
registration is being effected under the Securities Act pursuant to this Agreement of any Registrable Securities held by such selling
holder, indemnify and hold harmless the Company, each of its directors and officers and each Underwriter (if any), and each other selling
holder and each other person, if any, who controls another selling holder or such Underwriter within the meaning of the Securities Act,
against any losses, claims, judgments, damages or liabilities, whether joint or several, insofar as such losses, claims, judgments, damages
or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or allegedly untrue statement of a
material fact contained in any Registration Statement under which the sale of such Registrable Securities was registered under the Securities
Act, any preliminary prospectus, final prospectus or summary prospectus contained in the Registration Statement, or any amendment or
supplement to the Registration Statement, or arise out of or are based upon any omission or the alleged omission to state a material
fact required to be stated therein or necessary to make the statement therein not misleading, if the statement or omission was made in
reliance upon and in conformity with information furnished in writing to the Company by such selling holder expressly for use therein,
and shall reimburse the Company, its directors and officers, and each other selling holder or controlling person for any legal or other
expenses reasonably incurred by any of them in connection with investigation or defending any such loss, claim, damage, liability or
action. Each selling holder’s indemnification obligations hereunder shall be several and not joint and shall be limited to the
amount of any net proceeds actually received by such selling holder.

 

    	9

     

    

 

4.3
Conduct of Indemnification Proceedings. Promptly after receipt by any person of any notice of any loss, claim, damage or liability
or any action in respect of which indemnity may be sought pursuant to Section 4.1 or 4.2, such person (the “Indemnified Party”)
shall, if a claim in respect thereof is to be made against any other person for indemnification hereunder, notify such other person (the
“Indemnifying Party”) in writing of the loss, claim, judgment, damage, liability or action; provided, however,
that the failure by the Indemnified Party to notify the Indemnifying Party shall not relieve the Indemnifying Party from any liability
which the Indemnifying Party may have to such Indemnified Party hereunder, except and solely to the extent the Indemnifying Party is
actually prejudiced by such failure. If the Indemnified Party is seeking indemnification with respect to any claim or action brought
against the Indemnified Party, then the Indemnifying Party shall be entitled to participate in such claim or action, and, to the extent
that it wishes, jointly with all other Indemnifying Parties, to assume control of the defense thereof with counsel satisfactory to the
Indemnified Party. After notice from the Indemnifying Party to the Indemnified Party of its election to assume control of the defense
of such claim or action, the Indemnifying Party shall not be liable to the Indemnified Party for any legal or other expenses subsequently
incurred by the Indemnified Party in connection with the defense thereof other than reasonable costs of investigation; provided, however,
that in any action in which both the Indemnified Party and the Indemnifying Party are named as defendants, the Indemnified Party shall
have the right to employ separate counsel (but no more than one such separate counsel) to represent the Indemnified Party and its controlling
persons who may be subject to liability arising out of any claim in respect of which indemnity may be sought by the Indemnified Party
against the Indemnifying Party, with the fees and expenses of such counsel to be paid by such Indemnifying Party if, based upon the written
opinion of counsel of such Indemnified Party, representation of both parties by the same counsel would be inappropriate due to actual
or potential differing interests between them. No Indemnifying Party shall, without the prior written consent of the Indemnified Party,
consent to entry of judgment or effect any settlement of any claim or pending or threatened proceeding in respect of which the Indemnified
Party is or could have been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such judgment or
settlement includes an unconditional release of such Indemnified Party from all liability arising out of such claim or proceeding.

 

4.4
Contribution.

 

4.4.1
If the indemnification provided for in the foregoing Sections 4.1, 4.2 and 4.3 is unavailable to any Indemnified Party in respect of
any loss, claim, damage, liability or action referred to herein, then each such Indemnifying Party, in lieu of indemnifying such Indemnified
Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such loss, claim, damage, liability or
action in such proportion as is appropriate to reflect the relative fault of the Indemnified Parties and the Indemnifying Parties in
connection with the actions or omissions which resulted in such loss, claim, damage, liability or action, as well as any other relevant
equitable considerations. The relative fault of any Indemnified Party and any Indemnifying Party shall be determined by reference to,
among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a
material fact relates to information supplied by such Indemnified Party or such Indemnifying Party and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent such statement or omission.

 

    	10

     

    

 

4.4.2
The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 4.4 were determined by pro
rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the immediately
preceding Section 4.4.1.

 

4.4.3
The amount paid or payable by an Indemnified Party as a result of any loss, claim, damage, liability or action referred to in the immediately
preceding paragraph shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by such
Indemnified Party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section
4.4, no holder of Registrable Securities shall be required to contribute any amount in excess of the dollar amount of the net proceeds
(after payment of any underwriting fees, discounts, commissions or taxes) actually received by such holder from the sale of Registrable
Securities which gave rise to such contribution obligation. No person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.

 

5.
RULE 144.

 

The
Company covenants that it shall file any reports required to be filed by it under the Securities Act and the Exchange Act and shall take
such further action as the holders of Registrable Securities may reasonably request, all to the extent required from time to time to
enable such holders to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions
provided by Rule 144 under the Securities Act, as such Rules may be amended from time to time, or any similar rule or regulation hereafter
adopted by the Commission.

 

6.
MISCELLANEOUS.

 

6.1
Other Registration Rights. The Company represents and warrants that, except as disclosed in the Company’s registration statement
on Form S-1 (File No. 333-256455)1, no person, other than the holders of the Registrable Securities, has any right
to require the Company to register any of the Company’s share capital for sale or to include the Company’s share capital
in any registration filed by the Company for the sale of share capital for its own account or for the account of any other person.

 

6.2
Assignment; No Third Party Beneficiaries. This Agreement and the rights, duties and obligations of the Company hereunder may not
be assigned or delegated by the Company in whole or in part. This Agreement and the rights, duties and obligations of the holders of
Registrable Securities hereunder may be freely assigned or delegated by such holder of Registrable Securities in conjunction with and
to the extent of any transfer of Registrable Securities by any such holder. This Agreement and the provisions hereof shall be binding
upon and shall inure to the benefit of each of the parties, to the permitted assigns of the Investors or holder of Registrable Securities
or of any assignee of the Investors or holder of Registrable Securities. This Agreement is not intended to confer any rights or benefits
on any persons that are not party hereto other than as expressly set forth in Article 4 and this Section 6.2. Any additional holder of
Registrable Securities may become party to this Agreement by executing and delivering a joinder to the Company and the Sponsor in form
and substance reasonably satisfactory to the Company.

 

 

1
NTD: This might change depending upon any additional financing from PIPE investors.

 

    	11

     

    

 

6.3
Notices. All notices, demands, requests, consents, approvals or other communications (collectively, “Notices”)
required or permitted to be given hereunder or which are given with respect to this Agreement shall be in writing and shall be personally
served, delivered by reputable air courier service with charges prepaid, or transmitted by hand delivery, telegram, telex or facsimile,
addressed as set forth below, or to such other address as such party shall have specified most recently by written notice. Notice shall
be deemed given on the date of service or transmission if personally served or transmitted by telegram, telex or facsimile; provided,
that if such service or transmission is not on a business day or is after normal business hours, then such notice shall be deemed given
on the next business day. Notice otherwise sent as provided herein shall be deemed given on the next business day following timely delivery
of such notice to a reputable air courier service with an order for next-day delivery.

 

	 	To
    the Company:	 
	 	 	 
	 	____________________	 
	 	 	 
	 	____________________	 
	 	 	 
	 	____________________	 
	 	 	 
	 	Attn:
    _______________	 
	 	 	 
	 	Email:
    ______________	 
	 	 	 
	 	with
    a copy to:	 
	 	 	 
	 	____________________	 
	 	 	 
	 	____________________	 
	 	 	 
	 	____________________	 
	 	 	 
	 	Attn:
    _______________	 
	 	 	 
	 	Email:
    ______________	 

 

To
an Investor, to the address set forth below such Investor’s name on Exhibit A hereto.

 

6.4
Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof
shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any
such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision
as similar in terms to such invalid or unenforceable provision as may be possible that is valid and enforceable.

 

    	12

     

    

 

6.5
Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original, and all of which
taken together shall constitute one and the same instrument.

 

6.6
Entire Agreement. This Agreement (including all agreements entered into pursuant hereto and all certificates and instruments delivered
pursuant hereto and thereto) constitute the entire agreement of the parties with respect to the subject matter hereof and supersede all
prior and contemporaneous agreements, representations, understandings, negotiations and discussions between the parties, whether oral
or written; provided, that, for the avoidance of doubt, the foregoing shall not affect the rights and obligations of the parties under
the SPA. Without limiting the foregoing, the Pre-BC Investors hereby acknowledge and agree that this Agreement amends and restates and
supersedes the Original Registration Rights Agreement in its entirety.

 

6.7
Modifications and Amendments. No amendment, modification or termination of this Agreement shall be binding upon the Company unless
executed in writing by the Company. No amendment, modification or termination of this Agreement shall be binding upon the holders of
the Registrable Securities unless executed in writing by the holders of the majority Registrable Securities.

 

6.8
Titles and Headings. Titles and headings of sections of this Agreement are for convenience only and shall not affect the construction
of any provision of this Agreement.

 

6.9
Waivers and Extensions. Any party to this Agreement may waive any right, breach or default which such party has the right to waive,
provided that such waiver will not be effective against the waiving party unless it is in writing, is signed by such party, and specifically
refers to this Agreement. Waivers may be made in advance or after the right waived has arisen or the breach or default waived has occurred.
Any waiver may be conditional. No waiver of any breach of any agreement or provision herein contained shall be deemed a waiver of any
preceding or succeeding breach thereof nor of any other agreement or provision herein contained. No waiver or extension of time for performance
of any obligations or acts shall be deemed a waiver or extension of the time for performance of any other obligations or acts.

 

6.10
Remedies Cumulative. In the event that the Company fails to observe or perform any covenant or agreement to be observed or performed
under this Agreement, the Investor or any other holder of Registrable Securities may proceed to protect and enforce its rights by suit
in equity or action at law, whether for specific performance of any term contained in this Agreement or for an injunction against the
breach of any such term or in aid of the exercise of any power granted in this Agreement or to enforce any other legal or equitable right,
or to take any one or more of such actions, without being required to post a bond. None of the rights, powers or remedies conferred under
this Agreement shall be mutually exclusive, and each such right, power or remedy shall be cumulative and in addition to any other right,
power or remedy, whether conferred by this Agreement or now or hereafter available at law, in equity, by statute or otherwise.

 

    	13

     

    

 

6.11
Governing Law. This Agreement shall be governed by, interpreted under, and construed in accordance with the internal laws of the
State of New York applicable to agreements made and to be performed within the State of New York, without giving effect to any choice-of-law
provisions thereof that would compel the application of the substantive laws of any other jurisdiction. The venue for any action taken
with respect to the Agreement shall be any state or federal court in New York County in the State of New York.

 

6.12
Waiver of Trial by Jury. Each party hereby irrevocably and unconditionally waives the right to a trial by jury in any action,
suit, counterclaim or other proceeding (whether based on contract, tort or otherwise) arising out of, connected with or relating to this
Agreement, the transactions contemplated hereby, or the actions of the Investor in the negotiation, administration, performance or enforcement
hereof.

 

6.13
Termination of SPA. This Agreement shall be binding upon each party upon such party’s execution and delivery of this Agreement,
but this Agreement shall only become effective upon the Closing. In the event that the SPA is validly terminated in accordance with its
terms prior to the Closing, this Agreement shall automatically terminate and become null and void and be of no further force or effect,
and the parties shall have no obligations hereunder.

 

6.14
Term. This Agreement shall terminate upon the earlier of (i) the fifth anniversary of the date of this Agreement or, (ii) on the
date as of which (A) all of the Registrable Securities held by such holder have been sold pursuant to a Registration Statement (but in
no event prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor
rule promulgated thereafter by the Commission)) or (B) such holder of Registrable Securities is permitted to sell all of its Registrable
Securities under Rule 144 (or any similar provision) under the Securities Act without limitation on the amount of securities sold or
the manner of sale.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

 

    	14

     

    

 

IN
WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be executed and delivered by their duly authorized representatives
as of the date first written above.

 

	 	COMPANY:
	 	 	 
	 	8i
    Holdings Acquisition 2 Corp.
	 	 	 
	 	By:	 
	 	Name:	Meng
    Dong (James) Tan
	 	Title:	Chief
    Executive Officer

 

	 	INVESTORS:
	 	 	 
	 	8i
    Holdings 2 Pte Ltd
	 	 	 
	 	By:	 
	 	Name:	Meng
    Dong (James) Tan
	 	Title:	Director
	 	 	 
	 	 	 
	 	 	Meng
    Dong (James) Tan
	 	 	 
	 	 	 
	 	 	Guan
    Hong (William) Yap
	 	 	 
	 	 	 
	 	 	Alexander
    Arrow
	 	 	 
	 	 	 
	 	 	Kwong
    Yeow Liew
	 	 	 
	 	 	 
	 	 	Ajay
    Rajpal
	 	 	 
	 	Watermark
    Developments Limited
	 
	 	By:	 
	 	Name:	Kelvin
    Chen Wei Wen
	 	Title:	 

 

	 	ADVISOR:
	 	 	 
	 	Menora
    Capital Pte Ltd.
	 	 	 
	 	By:	 
	 	Name:	Chan
    Fook Meng
	 	Title:	Director

 

    	15

     

    

 

EXHIBIT
A

 

Name
and Address of Investors

 

To
all Investors:

 

8i
Holdings 2 Pte Ltd

c/o
6 Eu Tong Sen Street

#08-13
Central

Singapore
059817

 

Meng
Dong (James) Tan

c/o
8i Acquisition 2 Corp.

6
Eu Tong Sen Street

#08-13
Central

Singapore
059817

 

Guan
Hong (William) Yap

c/o
8i Acquisition 2 Corp.

6
Eu Tong Sen Street

#08-13
Central

Singapore
059817

 

Alexander
Arrow

c/o
8i Acquisition 2 Corp.

6
Eu Tong Sen Street

#08-13
Central

Singapore
059817

 

Kwong
Yeow Liew

c/o
8i Acquisition 2 Corp.

6
Eu Tong Sen Street

#08-13
Central

Singapore
059817

 

Ajay
Rajpal

c/o
8i Acquisition 2 Corp.

6
Eu Tong Sen Street

#08-13
Central

Singapore
059817

 

Watermark
Developments Limited

Watermark
Developments Limited

1
Pemimpin Drive

#02-02
One Pemimpin

Singapore
576152

Menora
Capital Ptd Ltd.

___________________________

___________________________

 

    	16

     

    

 

Annex
A

 

PLAN
OF DISTRIBUTION

 

The
Selling Stockholders and any of their pledgees, donees, assignees and successors-in-interest may, from time to time, sell any or all
of the Purchaser Shares being offered under this prospectus on any stock exchange, market or trading facility on which the Company’s
ordinary shares are traded or in private transactions. These sales may be at fixed or negotiated prices. The Selling Stockholder may
use any one or more of the following methods when disposing of the Purchaser Shares:

 

 ●
ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

 

 ●
block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block
as principal to facilitate the transaction;

 

 ●
purchases by a broker-dealer as principal and resales by the broker-dealer for its account;

 

 ●
an exchange distribution in accordance with the rules of the applicable exchange;

 

 ●
privately negotiated transactions;

 

 ●
to cover short sales made after the date that the registration statement of which this prospectus is a part is declared effective
by the SEC;

 

 ●
broker-dealers may agree with the Selling Stockholders to sell a specified number of such shares at a stipulated price per share;

 

 ●
firm commitment underwritten transactions;

 

 ●
a combination of any of these methods of sale; and

 

 ●
any other method permitted pursuant to applicable law.

 

The
Purchaser Shares may also be sold under Rule 144 under the Securities Act, if available for the Selling Stockholders, rather than under
this prospectus. The Selling Stockholders have the sole and absolute discretion not to accept any purchase offer or make any sale of
Purchaser Shares if it deems the purchase price to be unsatisfactory at any particular time.

 

The
Selling Stockholders may pledge their Purchaser Shares to their brokers under the margin provisions of customer agreements. If a Selling
Stockholder defaults on a margin loan, the broker may, from time to time, offer and sell the pledged Purchaser Shares.

 

    	17

     

    

 

Broker-dealers
engaged by the Selling Stockholders may arrange for other broker-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in
amounts to be negotiated, which commissions as to a particular broker or dealer may be in excess of customary commissions to the extent
permitted by applicable law.

 

If
sales of Purchaser Shares offered under this prospectus are made to broker-dealers as principals, we would be required to file a post-effective
amendment to the registration statement of which this prospectus is a part. In the post-effective amendment, we would be required to
disclose the names of any participating broker-dealers and the compensation arrangements relating to such sales.

 

The
Selling Stockholders and any broker-dealers or agents that are involved in selling the Purchaser Shares offered under this prospectus
may be deemed to be “underwriters” within the meaning of the Securities Act in connection with these sales. Commissions received
by these broker-dealers or agents and any profit on the resale of the Purchaser Shares purchased by them may be deemed to be underwriting
commissions or discounts under the Securities Act. Any broker-dealers or agents that are deemed to be underwriters may not sell Purchaser
Shares offered under this prospectus unless and until we set forth the names of the underwriters and the material details of their underwriting
arrangements in a supplement to this prospectus or, if required, in a replacement prospectus included in a post-effective amendment to
the registration statement of which this prospectus is a part.

 

    	18Exhibit
10.3 

 

SELLER
RELEASE

 

This
Seller Release (this “Release”) is dated as of this ____ day of April, 2022, by and among Watermark
Developments Limited, a British Virgin Islands corporation (the “Releasing Party”), in its capacity as the
sole stockholder of Euda Health Limited, a British Virgin Islands corporation (the “Company”), the Company,
and 8i Acquisition 2 Corp., a British Virgin Islands corporation (“Purchaser”). Capitalized terms used herein,
but not otherwise defined, shall have the meaning ascribed to them in the Purchase Agreement (as defined below).

 

WHEREAS,
the Releasing Party, the Company, and Purchaser have entered into that certain Stock Purchase Agreement dated as of March ___, 2022 (as
such agreement may be amended, modified or supplemented and in effect from time to time, the “Purchase Agreement”),
pursuant to which Purchaser will, at the Closing, purchase all of the Company Ordinary Shares from the Releasing Party.

 

NOW,
THEREFORE, for valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Release do hereby
agree as follows:

 

1.
The Releasing Party, on behalf of itself and its Affiliates, heirs, assigns and
representatives, and any Person claiming by, through or under any of the foregoing, releases, remises, acquits and forever
discharges Purchaser, the Company, the Company Subsidiaries and all of their respective past and present officers, directors,
managers, stockholders, members, employees, agents, predecessors, Subsidiaries, Affiliates, estates, successors, assigns, partners
and attorneys (each, a “Released Party”) to the maximum extent permitted by Law, from any and all claims,
obligations, rights, liabilities or commitments of any nature whatsoever (collectively, the “Claims”),
whether known or unknown, suspected or unsuspected, that the Releasing Party, individually or as a member of any class, now has,
owns or holds or has at any time heretofore ever had, owned or held, or may in the future have, own or hold against Purchaser, the
Company and the other Released Parties, arising at or prior to the Closing, or related to any act, omission or event occurring, or
condition existing, at or prior to the Closing. Notwithstanding the foregoing, this Release shall not act in any manner to waive or
release any Claims against Purchaser, the Company or the Company Subsidiaries or any other Released Party (i) arising in the first
instance after the date of this Release under the Purchase Agreement or any other agreements, documents or instruments contemplated
by or entered into pursuant to the Purchase Agreement, and (ii) under the organizational or governing documents of, or any
indemnification agreements with, the Purchaser or any of its Subsidiaries (including, without limitation, the Company and the
Company Subsidiaries). The Claims released by the Releasing Party under this Section 1 are collectively referred to herein as
the “Released Claims”.

 

2. The
Releasing Party hereby represents, warrants and covenants to each Released Party that there has not been and will not be any assignment
or other transfer of any right or interest in any Released Claims, and hereby agrees to indemnify and hold each Released Party harmless
from any Damages directly or indirectly incurred by any of the Released Parties as a result of any Person asserting any right or interest
pursuant to any such purported assignment or transfer of any such right or interest.

 

    	 

    	 

    

 

3. The
Releasing Party hereby agrees that if the Releasing Party hereafter commences, joins in, or in any manner seeks relief through any Proceeding
arising out of, based upon, or relating to any of the Released Claims, or in any manner asserts against any Released Party any of the
Released Claims, then the Releasing Party will pay to such Released Party, in addition to any other Damages, direct or indirect, all
attorneys’ fees incurred in defending or otherwise responding to such Proceeding.

 

4. The
provisions of this Release are (i) intended to be for the benefit of, and shall be enforceable by each Released Party, it being expressly
agreed that such Persons shall be third party beneficiaries of this Release to the extent not a party hereto, and (ii) in addition to,
and not in substitution for, any other right to indemnification or contribution that any such Person may have by contract or otherwise.

 

5. If
any provision of this Release shall hereafter be held to be invalid or unenforceable for any reason, that provision shall be reformed
to the maximum, extent permitted to preserve the parties’ original intent; failing which, it shall be severed from this Release
with the balance of this Release continuing in full force and effect. Such occurrence shall not have the effect of rendering the provision
in question invalid in any other jurisdiction or in any other case or circumstances, or of rendering invalid any other provisions contained
therein to the extent that such other provisions are not themselves actually in conflict with any applicable Law.

 

6. This
Release shall be governed and construed in accordance with the internal laws of the State of New York.

 

7. Each
of the parties irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of, and venue in,
any New York state court, or, if no such state court has proper jurisdiction, the United States District Court for the Southern District
of New York and in either case, any appellate court thereof, in any Proceeding arising out of or relating to this Release or the transactions
contemplated hereby or for recognition or enforcement of any judgment relating thereto, and each of the parties hereby irrevocably and
unconditionally (a) agrees not to commence any such Proceeding except in such courts, (b) agrees that any Claim in respect of any such
Proceeding may be heard and determined in such New York state court, or if no such state has proper jurisdiction, then such Federal court,
(c) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying
of venue of any such Proceeding in such New York state or Federal court, and (d) waives, to the fullest extent permitted by Law, the
defense of an inconvenient forum to the maintenance of such Proceeding in such New York state or Federal court. Each of the parties hereto
agrees that a judgment in any such Proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment
or in any other manner provided by Law. Each party to this Release irrevocably consents to service of process in the manner provided
for notices in Section 12.6 of the Purchase Agreement. Nothing in this Release will affect the right of any party to this Release to
serve process in any other manner permitted by Law.

 

    	2

     

    

 

8. If
any Proceeding is brought related to this Release or the enforcement of any provision hereof, the successful or prevailing party shall
be entitled to recover its reasonable attorneys’ fees and other costs incurred in that Proceeding, in addition to any other relief
to which it may be entitled.

 

9. EACH
PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS RELEASE IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT
ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION
DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS RELEASE AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREBY. EACH PARTY
CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY PROCEEDING, SEEK TO ENFORCE SUCH WAIVER, (B) IT UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATIONS OF SUCH WAIVER, (C) IT MAKES SUCH WAIVER VOLUNTARILY, AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS RELEASE BY, AMONG OTHER
THINGS, THE WAIVER AND CERTIFICATIONS IN THIS RELEASE.

 

10. This
Release may be executed and delivered electronically (including by pdf transmission) and in several counterparts, each of which shall
constitute an original and all of which, when taken together, shall constitute one agreement.

 

11. This
Release may be amended, modified and supplemented only by a written instrument executed by all of the parties hereto.

 

Signature
page follows

 

    	3

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed and delivered this Release as of the date first written above.

 

	 	COMPANY:
	 	 	 
	 	Euda Health Limited
	 	 	                     
	 	By:	
	 	Name:	
	 	Title:	
	 	 	 
	 	PURCHASER:
	 	 	 
	 	8i Acquisition 2 Corp.
	 	 	 
	 	By:	
	 	Name:	
	 	Title:	
	 	 	 
	 	RELEASING PARTY:
	 	 	 
	 	Watermark Developments Limited
	 	 	 
	 	By:	
	 	Name:	
	 	Title:	

 

[Signature
Page – Seller Release]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]